EncephalX is a Sherbrooke-based medical technology venture focused on redefining post-trauma and post-stroke cranial care through its flagship Dynamic Cranioplasty System (DCPS). The DCPS replaces the current two-stage craniectomy/cranioplasty workflow with a single operation that offers continuous intracranial pressure decompression, aiming to improve patient outcomes and shorten hospital stays. The technology originated from academic research into cranial defects and has been refined in close collaboration with practicing neurosurgeons, including the company’s medical director, Dr. Christian Iorio-Morin. Management plans to use its newly raised capital to achieve the first-in-human implantation and advance regulatory approval of the fully developed surgical kit. Longer-term goals include building additional clinical, regulatory, and industrial partnerships and expanding the platform internationally. No revenue or user metrics have been disclosed to date.

Total raised

$3M

Funding rounds

2

Latest round

Seed

Latest activity

Jan 2026